Opdivo (nivolumab)

pCPA File Number: 21111
Negotiation Status:
Concluded with an LOI
Indication(s):
Melanoma adjuvant therapy
Sponsor/Manufacturer:
Bristol Myers Squibb Canada Inc.
CADTH Project Number:
pCODR 10147
pCPA Engagement Letter Issued:
Negotiation Process Concluded: